Journal
DIGESTIVE DISEASES
Volume 29, Issue 3, Pages 339-364Publisher
KARGER
DOI: 10.1159/000327577
Keywords
Clinical practice guidelines, evidence-based; Clinical practice manual, consensus-based; Hepatocellular carcinoma, prevention; Hepatocellular carcinoma, staging; Hepatocellular carcinoma, surveillance; Hepatocellular carcinoma, diagnostic algorithm; Hepatocellular carcinoma, treatment algorithm
Categories
Funding
- Grants-in-Aid for Scientific Research [23590962] Funding Source: KAKEN
Ask authors/readers for more resources
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized. Copyright (C) 2011 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available